slider1public sliderpublic01 sliderpublic02 sliderpublic03

Publications 2006 - 2010

2006

  1. KottaridiBolanaki E., MamurisZ., StathopoulosC.andMarkoulatosP. Molecular phylogeny of VP1, 2A and 2B genes of echovirus isolates: epidemiological linkage and observations on genetic variation 151: 1117-1132.
  2. PaximadiE., KarakasiliotisI., MamurisZ., StathopoulosC., KrikelisV. andMarkoulatosP. GenomicanalysisrecombinantSabinclinicalisolatesVirus Genes 32: 203-210. (IF: )
  3. Vourekas A., Kalavrizioti D., Stathopoulos C., (*) and Drainas D. Modulation of catalytic RNA biological activity by small molecule effectors. 6: 971-978. (*) corresponding author
  4. Kalavrizioti D. Vourekas A., Stamatopoulou, V., Toumpeki C., Giannouli S., Stathopoulos C., (*) and Drainas D. RNA-mediated therapeutics: from gene inactivation to clinical application 6: 1737-1758. (*) corresponding author
  5. Bailly M., Giannouli S., Blaise M., Stathopoulos C. (*), Kern D and Becker H. D. A single tRNA base-pair mediates bacterial tRNA-dependent biosynthesis of 34: 6083-6094. (*) correspondingauthor

2007

  1. Vourekas A., Kalavrizioti D., Tekos A., Zarkadis I., Stathopoulos C. (*) and Drainas D. A 40.7 kDa Rpp30/Rpp1 homologue is a protein subunit of Dictyostelium discoideum RNase P holoenzyme. Biochimie 89: 301-310. (*) corresponding author
  2. Stagos, Spanou, Margariti, Stathopoulos, Mamuris, Kazantzoglou, MagiatisKouretasD. (2007) Cytogeneticeffectsgrapeextracts (Vitisvinifera) andpolyphenolsmitomycinC-inducedSCEsinhumanbloodlymphocytes. J Agric. Food Chem. 55: 5246-5252.
  3. Zifa E., Giannouli S., Theotokis P., Stamatis K., Mamuris Z. and Stathopoulos C. (*) Mitochondrial tRNA mutations: functional and clinical perturbations. RNAbiology 4: 38-66. (*) corresponding author
  4. Kontou M., Kristo I., Ikonomidis A., Maniatis A., Pournaras S. and Stathopoulos C. (*)Molecular cloning and biochemical characterization of VIM-12, a novel hybrid metallo-β-lactamase from a Klebsiella pneumoniae clinical isolate, reveals atypical substrate specificity. Biochemistry 46: 13170-13178. (*) corresponding author

2008

  1. StamatisC., Giannouli, S., Suchentrunk F., Sert H., StathopoulosC. (*)andMamurisZ. RecruitmentmitochondrialtRNAgenesasauxiliary variability markersfor both intra- and inter-species analyses: theparadigmbrownhare (Lepuseuropaeus)Gene 410: 154-164. (*) corresponding author
  2. Zifa E., Theotokis P., Kaminari A., Maridaki H., Leze H., Petsiava E., Mamuris Z. and Stathopoulos C. (*) (2008) A novel G3337A mitochondrial ND1 mutation related to cardiomyopathy co-segregates with tRNALeu(CUN) A12308G and tRNAThr C15946T mutations. Mitochondrion 8: 229-236. (*) corresponding author
  3. Ikonomidis A., Michail G., Vasdeki A., Labrou M., Karavasilis V., Stathopoulos C., Maniatis A. and Pournaras S. (2008) In vitro and in vivo evaluation of oxacillin efficiency on mecA-positive oxacillin-susceptible Staphylococcus aureus. Antimicrob. Agents Chem. 52: 3905-3908.

2009

  1. Balatsos N. A. A., Anastasakis D. and Stathopoulos C. (*) Inhibition of human poly(A)-specific ribonuclease (PARN) by purine nucleotides: kinetic analysis. J. Enz. Inh. Med. 24: 516-523. (*) corresponding author
  2. GiannouliS., KyritsisA., Malissovas N., BeckerH. D. andStathopoulosC. (*)On the role of an unusual tRNAGly isoacceptor in Staphylococcus aureus. Biochimie 91: 344-351. (*) corresponding author
  3. Papatheodorou L. K., MalizosK. N., Poultisidis L. A., Hantes M. E., GiannouliS., Grafanaki K., Ioannou M. G., Koukoulis G. K., Protopappas V. C., Fotiadis D. I. andStathopoulosC.Ultrasound Med. Biol. 35: 576-584.
  4. Balatsos N. A. A., Vlachakis D., Maragozidis P., Manta S., Anastasakis D., Kyritsis A., Vlassi M., Komiotis D. and Stathopoulos C. (*) . Biochemistry 48: 6044-6051. (*) correspondingauthor

2010

  1. GiannouliS., LabrouM., KyritsisA., IkonomidisA., PournarasS., StathopoulosC. (*) and Tsakris A. (2010) DetectionmutationsinFemABXproteinfamilyin-susceptible, mecApositiveStaphylococcusaureusclinicalisolatesJ. Antimicrob. 65: 626-633. (*) correspondingauthor